Blog
Careers, Industries & Professions
Derivatives
Economics
Equities & Stocks
Foreign Exchange
International Business
Management & Leadership
Marketing & Sales
Personal Finance
Real Estate
CRISPR Therapeutics Is Upgraded After $900 Million Deal
Text size CRISPR shares rose in response to news of the deal on Tuesday. Dreamstime A day after CRISPR Therapeutics said that Vertex Pharmaceuticals would pay it $900 million for…